Working… Menu

Trial of ADT and SBRT Versus SBRT for Intermediate Prostate Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03056638
Recruitment Status : Recruiting
First Posted : February 17, 2017
Last Update Posted : March 11, 2021
Ferring Pharmaceuticals
University of Texas Southwestern Medical Center
University of Michigan
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : February 2022
Estimated Study Completion Date : February 2022